🔥The 9th Round of Easy Loan, Earn $40 Reward is in progress❗️ ⏰ Promotion Period: January 15th - Feburary 15th, 2025 👉 Register now and check more details at gate.io/campaigns/358

Submit an abstract by April 1 for the Fourth AACR International Meeting on Advances in Malignant Lymphoma (June 19-22, Philadelphia), chaired by Michael R. Green and organized in association with Blood Cancer Discovery. Learn more: bit.ly/43pICdk #AACRlymph24 Michael Green, PhD

This is team science! 🤝 A big shoutout to Lee Grimes Lab, Diane Krause, University of Pittsburgh (Singh lab) & Jordan Lab. Funded mostly by an RC2 grant from NIH, NIDDK, Shilpa Hattiangadi. Kudos to BioLegend, Cytek Biosciences & Curiox Biosystems for their support with prototype products! 3/3

Submit an abstract by April 1 for the Fourth AACR International Meeting on Advances in Malignant Lymphoma (June 19-22, Philadelphia), chaired by Michael R. Green and organized in association with Blood Cancer Discovery. Learn more: bit.ly/49fzmK6 #AACRlymph24 Michael Green, PhD

The abstract deadline is approaching. This is set to be a great conference with an excellent speaker line-up and formatted to support debate and interaction. Come and join us in Philly. #lmsm Melnick Lab Christopher Flowers Francesco Bertoni

The abstract deadline is this Friday for the AACR/ICML International Meeting on Advances in Malignant Lymphoma. Come and join us at this one-of-a-kind Lymphoma-focused meeting. #lmsm

Opening the @aacr Advances in Malignant Lymphoma meeting tonight with a fabulous keynote from Dr. Tak Mak, University of Toronto. Tet2+Idh2 mutations in AITL makes T-cells "party hard in the germinal center". #AACRlymph24

Ready for day 2 of the AACR Advances in Malignant Lymphoma meeting. Kicking off the morning with abstract presentations, then into sessions on premilgnancy and clonal precursors. Looking forward to it! #aacrlymph24 Blood Cancer Discovery #lmsm

Thank you to AACR, Margaret Foti, PhD, MD (hc), Blood Cancer Discovery and International Conference on Malignant Lymphoma for supporting #aacrlymph24, and for all that attended. It was a great opportunity for interaction and idea exchange to drive lymphoma research forward. Looking forward to the next meeting in 2 years. Pencil it in! #lmsm

Transcriptional/epigenetic chemical inducers of proximity (TCIPs) are an innovative new class of therapeutics that are set to impact lymphoma and other malignancies. Here Roman Sarott, Sai Gourisankar describe a CDK9 "catch and release" MOA for a new TCIP. science.org/doi/10.1126/sc…

Voting is open for the ASCO elections. Please consider casting a vote for Dr. Jason Westin Jason Westin, MD FACP FASCO for the Board of Directors. Jason is a thoughtful and visionary leader with a proven track record of contribution to ASCO. #lmsm MD Anderson Cancer Center

#ESHLYMPHOID2025 REGISTRATION AND ABSTRACT SUBMISSION ARE OPEN ➡ bit.ly/4cTSoce Oct 2-4, 2025 in Estoril, Portugal 🇵🇹 8th Translational Research Conference LYMPHOID MALIGNANCIES Chairs: Michael Hallek, Georg Lenz, Laurie Sehn, Louis Staudt, Catherine Wu #ESHCONFERENCES

Why is it that journals do not have the same data sharing standards for pharma as they do for academia? There is always a vague statement that you can email the company to request the data. But, after you've told the company all your ideas, the answer is invariably no.

For those of you who have had a hard time with papers, this was a doozie. Several editorial desk rejections, all for different reasons, and then an extensive 41-page rebuttal required for revision at Blood. All told, ~2 years from first submission to acceptance. Just keep at it!!

Thrilled to see David Russler-Germain, MD/PhD present our work as a plenary at #18ICML, with excellent discussion from Steve Ansell. The paper will be online tonight, with a summary to follow.

Lymphoma Microenvironment Archetype Profiles (LymphoMAPs). Just presented by David Russler-Germain, MD/PhD at #18icml International Conference on Malignant Lymphoma, now available online in Cancer Cell. #lmsm WashU Medicine MD Anderson Cancer Center. cell.com/cancer-cell/fu…